» Articles » PMID: 33922907

: A Quick Review on Identification, Current Treatments, and Challenges

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 30
PMID 33922907
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

is a novel and major fungal pathogen that has triggered several outbreaks in the last decade. The few drugs available to treat fungal diseases, the fact that this yeast has a high rate of multidrug resistance and the occurrence of misleading identifications, and the ability of forming biofilms (naturally more resistant to drugs) has made treatments of infections highly difficult. This review intends to quickly illustrate the main issues in identification, available treatments and the associated mechanisms of resistance, and the novel and alternative treatment and drugs (natural and synthetic) that have been recently reported.

Citing Articles

First Case of Candida Auris Sepsis in Southern Italy: Antifungal Susceptibility and Genomic Characterisation of a Difficult-to-Treat Emerging Yeast.

Stolfa S, Caggiano G, Ronga L, Dalfino L, Centrone F, Sallustio A Microorganisms. 2024; 12(10).

PMID: 39458271 PMC: 11509443. DOI: 10.3390/microorganisms12101962.


Prevalence and Outcomes of Candida auris Infections in a Tertiary Hospital in the United Arab Emirates (UAE).

Subhi A, Alshamsi S, Vitus A, Harazeen A Cureus. 2024; 16(9):e69988.

PMID: 39445294 PMC: 11497757. DOI: 10.7759/cureus.69988.


Resistance and virulence genes characteristic of a South Asia Clade (I) Candida auris strain isolated from blood in Beijing.

Yang J, Ma G, Li Y, Shi Y, Liang G Clinics (Sao Paulo). 2024; 79:100497.

PMID: 39284275 PMC: 11419799. DOI: 10.1016/j.clinsp.2024.100497.


Candida auris-a systematic review to inform the world health organization fungal priority pathogens list.

Kim PhD H, Nguyen MSc T, Kidd PhD S, Chambers MD J, Alastruey-Izquierdo PhD A, Shin MD J Med Mycol. 2024; 62(6).

PMID: 38935900 PMC: 11210622. DOI: 10.1093/mmy/myae042.


Unveiling the antifungal mechanisms of CTP, a new copper(II)-theophylline/1,10-phenanthroline complex, on drug-resistant non-albicans Candida species.

Frota H, Barbosa P, Lorentino C, Affonso L, Ramos L, Oliveira S Biometals. 2024; 37(5):1237-1253.

PMID: 38874822 DOI: 10.1007/s10534-024-00605-1.


References
1.
Barnes R, Gow N, Denning D, May R, Haynes K . Antifungal resistance: more research needed. Lancet. 2014; 384(9952):1427. DOI: 10.1016/S0140-6736(14)61861-4. View

2.
Sharma C, Kumar N, Meis J, Pandey R, Chowdhary A . Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India. Genome Announc. 2015; 3(4). PMC: 4505117. DOI: 10.1128/genomeA.00722-15. View

3.
Theill L, Dudiuk C, Morales-Lopez S, Berrio I, Rodriguez J, Marin A . Single-tube classical PCR for Candida auris and Candida haemulonii identification. Rev Iberoam Micol. 2018; 35(2):110-112. DOI: 10.1016/j.riam.2018.01.003. View

4.
Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M . Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One. 2018; 13(4):e0195743. PMC: 5891028. DOI: 10.1371/journal.pone.0195743. View

5.
Sexton D, Bentz M, Welsh R, Litvintseva A . Evaluation of a new T2 Magnetic Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples. Mycoses. 2018; 61(10):786-790. DOI: 10.1111/myc.12817. View